Dermatoscopy Guided Resection for Skin Cancer

Dermatoscopy Guided Resection Margins in Basal Cell Carcinoma and Cutaneos Squamous Cell Carcinoma

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06342297

Enrollment

400

Registered

2024-04-02

Start date

2024-01-14

Completion date

2026-01-14

Last updated

2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Surgical Margin

Keywords

Dermatoscopy

Brief summary

In this randomizid controlled trial the aim is to use dermatoscopy in deciding the resection margin for patients with suspected or verified basal cell carcinoma or cutaneous squamous cell carcinoma. The outcome is radical/non radical resection of the lateral margins in the pathology report.

Detailed description

In basal cell carcinoma and especially cutaneous squamous cell carcinoma the prognosis is very good if the tumour is radically removed in the primary resection. In this study we propose that the use of dermatoscopy in deciding the surgical margins can increase the proportion of radically removed tumours. In this randomized clinical trial the use of dermatoscopy in deciding the surgical margins in patients with suspected or verified basal cell carcinoma or cutaneous squamous cell carcinoma is assessed. The outcome measure is radical/non radical resection of the lateral margins. In the control group dematoscopy is not used in deciding the surgical margin. 400 patients with suspected or verified BCC or cSCC will be included, 200 in each group.

Interventions

DEVICEDermatoscopy

Dermatoscopy used in decision of surgical margin before resection of basal cell carcinoma or cutaneous squamous cell carcinoma

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with primary suspected or verified basal cell carcinoma or cutaneous cell carcinoma

Exclusion criteria

* Recurrent tumours * Previous radiotherapy of the tumour area * If the patient cannot understand the study i nformation

Design outcomes

Primary

Measure	Time frame	Description
Pathology resection side margin (radical/not radical)	Pathology report usually within two weeks after surgery	If the side margins in the pathology report is radical or not

Countries

Sweden

Contacts

Primary ContactFredrik Landström, MD, PhD

fredrik.landstrom@regionorebrolan.se019 602 14 68

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026